ARTICLE | Company News
Oxxon and Ludwig in research agreement
December 13, 2000 8:00 AM UTC
Oxxon Pharmaccines (Oxford, U.K.) will license certain cancer antigens from the Ludwig Institute for Cancer Research (Oxford, U.K.) for use in Oxxon's therapeutic cancer vaccines. ...